Skip to main content
. 2014 Mar 4;2014:652750. doi: 10.1155/2014/652750

Table 3.

Onset and end of (pseudo) hallucinations reported from/observed in 11 subjects during the course of the clinical trial.

Subject number Dosing times* Number of episodes Onset* End*
2 08:05 and 20:05 1 C: 00:15 00:45

3 08:10 and 20:10 1 C: 01:30 02:00

5 08:20 and 20:20 1 C: 23:30 01:30

6 08:25 and 20:25 2 C: 01:07 02:00
C: 01:30 08:00

8 08:00 and 20:00 1 C: 08:45 08:55

9 08:00 and 20:00 1 C: 23:00 23:30

10 08:05 and 20:05 1 C: 01:00 02:30

13 08:20 and 20:20 1 C: 00:30 00:35

15 08:15 and 20:15 3
S: 09:50 11:00
C: 00:00 03:00

16 08:25 and 20:25 11
C: 02:00 03:00
C: 00:00 07:30
C: 00:00 02:30
C: 23:30 08:00
S: 22:00 08:00
S: 21:30 03:30
S: 21:00 09:00
S: 21:15 07:29
S: 21:30 08:00
S: 21:25 07:30
S: 21:30 23:00

17 08:30 and 20:30 1 C: 00:20 03:30

*Clock time (h:minutes); C: complex (pseudo) hallucination; S: simple (pseudo) hallucination. Insomnia: 11–19; 24–28.